333 related articles for article (PubMed ID: 29142106)
21. An astrocyte cell line that differentially propagates murine prions.
Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
[TBL] [Abstract][Full Text] [Related]
22. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.
Abu Rumeileh S; Lattanzio F; Stanzani Maserati M; Rizzi R; Capellari S; Parchi P
J Alzheimers Dis; 2017; 55(4):1471-1480. PubMed ID: 27886009
[TBL] [Abstract][Full Text] [Related]
24. Immunization with either prion protein fragment 95-123 or the fragment-specific antibodies rescue memory loss and neurodegenerative phenotype of neurons in olfactory bulbectomized mice.
Bobkova NV; Medvinskaya NI; Kamynina AV; Aleksandrova IY; Nesterova IV; Samokhin AN; Koroev DO; Filatova MP; Nekrasov PV; Abramov AY; Leonov SV; Volpina OM
Neurobiol Learn Mem; 2014 Jan; 107():50-64. PubMed ID: 24239620
[TBL] [Abstract][Full Text] [Related]
25. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.
Resenberger UK; Harmeier A; Woerner AC; Goodman JL; Müller V; Krishnan R; Vabulas RM; Kretzschmar HA; Lindquist S; Hartl FU; Multhaup G; Winklhofer KF; Tatzelt J
EMBO J; 2011 May; 30(10):2057-70. PubMed ID: 21441896
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of quality control proteins reduces prion conversion in prion-infected cells.
Thapa S; Abdulrahman B; Abdelaziz DH; Lu L; Ben Aissa M; Schatzl HM
J Biol Chem; 2018 Oct; 293(41):16069-16082. PubMed ID: 30154245
[TBL] [Abstract][Full Text] [Related]
27. Mutated but Not Deleted Ovine PrP(C) N-Terminal Polybasic Region Strongly Interferes with Prion Propagation in Transgenic Mice.
Khalifé M; Reine F; Paquet-Fifield S; Castille J; Herzog L; Vilotte M; Moudjou M; Moazami-Goudarzi K; Makhzami S; Passet B; Andréoletti O; Vilette D; Laude H; Béringue V; Vilotte JL
J Virol; 2016 Feb; 90(3):1638-46. PubMed ID: 26608316
[TBL] [Abstract][Full Text] [Related]
28. Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development.
Baier M; Apelt J; Riemer C; Gültner S; Schwarz A; Bamme T; Burwinkel M; Schliebs R
Int J Dev Neurosci; 2008 Nov; 26(7):821-4. PubMed ID: 18662767
[TBL] [Abstract][Full Text] [Related]
29. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
30. On the biology of prions.
Prusiner SB; Gabizon R; McKinley MP
Acta Neuropathol; 1987; 72(4):299-314. PubMed ID: 3554880
[TBL] [Abstract][Full Text] [Related]
31. Genetic and infectious prion diseases.
Prusiner SB
Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
[TBL] [Abstract][Full Text] [Related]
32. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
Rigter A; Bossers A
J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?
Igel-Egalon A; Bohl J; Moudjou M; Herzog L; Reine F; Rezaei H; Béringue V
Viruses; 2019 May; 11(5):. PubMed ID: 31083283
[TBL] [Abstract][Full Text] [Related]
34. The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.
Iida M; Mashima T; Yamaoki Y; So M; Nagata T; Katahira M
FEBS J; 2019 Jun; 286(12):2355-2365. PubMed ID: 30916478
[TBL] [Abstract][Full Text] [Related]
35. Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture.
Lawson VA; Vella LJ; Stewart JD; Sharples RA; Klemm H; Machalek DM; Masters CL; Cappai R; Collins SJ; Hill AF
Int J Biochem Cell Biol; 2008; 40(12):2793-801. PubMed ID: 18590830
[TBL] [Abstract][Full Text] [Related]
36. Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions.
Chapuis J; Moudjou M; Reine F; Herzog L; Jaumain E; Chapuis C; Quadrio I; Boulliat J; Perret-Liaudet A; Dron M; Laude H; Rezaei H; Béringue V
Acta Neuropathol Commun; 2016 Feb; 4():10. PubMed ID: 26847207
[TBL] [Abstract][Full Text] [Related]
37. The spatial patterns of prion protein deposits in Creutzfeldt-Jakob disease: comparison with beta-amyloid deposits in Alzheimer's disease.
Armstrong RA; Lantos PL; Cairns NJ
Neurosci Lett; 2001 Jan; 298(1):53-6. PubMed ID: 11154834
[TBL] [Abstract][Full Text] [Related]
38. Cerebral amyloidoses: molecular pathways and therapeutic challenges.
Monaco S; Zanusso G; Mazzucco S; Rizzuto N
Curr Med Chem; 2006; 13(16):1903-13. PubMed ID: 16842201
[TBL] [Abstract][Full Text] [Related]
39. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases.
Sandberg MK; Al-Doujaily H; Sharps B; Clarke AR; Collinge J
Nature; 2011 Feb; 470(7335):540-2. PubMed ID: 21350487
[TBL] [Abstract][Full Text] [Related]
40. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
